Literature DB >> 22934615

Design and synthesis of a stable oxidized phospholipid mimic with specific binding recognition for macrophage scavenger receptors.

William W Turner1, Karsten Hartvigsen, Agnes Boullier, Erica N Montano, Joseph L Witztum, Michael S VanNieuwenhze.   

Abstract

Macrophage scavenger receptors appear to play a major role in the clearance of oxidized phospholipid (OxPL) products. Discrete peptide-phospholipid conjugates with the phosphatidylcholine headgroup have been shown to exhibit binding affinity for these receptors. We report the preparation of a water-soluble, stable peptide-phospholipid conjugate (9) that possesses the necessary physical properties to enable more detailed study of the role(s) of OxPL in metabolic disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22934615      PMCID: PMC3465084          DOI: 10.1021/jm300685s

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  26 in total

Review 1.  Innate and acquired immunity in atherogenesis.

Authors:  Christoph J Binder; Mi-Kyung Chang; Peter X Shaw; Yury I Miller; Karsten Hartvigsen; Asheesh Dewan; Joseph L Witztum
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

2.  Oxidized low-density lipoprotein and atherosclerosis.

Authors:  Daniel Steinberg; Joseph L Witztum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12       Impact factor: 8.311

Review 3.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

Review 4.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

5.  The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein.

Authors:  A Boullier; K L Gillotte; S Hörkkö; S R Green; P Friedman; E A Dennis; J L Witztum; D Steinberg; O Quehenberger
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

6.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.

Authors:  P X Shaw; S Hörkkö; M K Chang; L K Curtiss; W Palinski; G J Silverman; J L Witztum
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  CD36 is a receptor for oxidized low density lipoprotein.

Authors:  G Endemann; L W Stanton; K S Madden; C M Bryant; R T White; A A Protter
Journal:  J Biol Chem       Date:  1993-06-05       Impact factor: 5.157

8.  Identification of core aldehydes among in vitro peroxidation products of cholesteryl esters.

Authors:  H Kamido; A Kuksis; L Marai; J J Myher
Journal:  Lipids       Date:  1993-04       Impact factor: 1.880

9.  Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36.

Authors:  Eugene A Podrez; Eugenia Poliakov; Zhongzhou Shen; Renliang Zhang; Yijun Deng; Mingjiang Sun; Paula J Finton; Lian Shan; Bogdan Gugiu; Paul L Fox; Henry F Hoff; Robert G Salomon; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-07-08       Impact factor: 5.157

10.  A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

Authors:  Eugene A Podrez; Eugenia Poliakov; Zhongzhou Shen; Renliang Zhang; Yijun Deng; Mingjiang Sun; Paula J Finton; Lian Shan; Maria Febbraio; David P Hajjar; Roy L Silverstein; Henry F Hoff; Robert G Salomon; Stanley L Hazen
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

View more
  5 in total

Review 1.  Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions.

Authors:  Karen Briley-Saebo; Calvin Yeang; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Cardiovasc Transl Res       Date:  2014-10-09       Impact factor: 4.132

2.  Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles.

Authors:  Shufang Nie; Jia Zhang; Raul Martinez-Zaguilan; Souad Sennoune; Md Nazir Hossen; Alice H Lichtenstein; Jun Cao; Gary E Meyerrose; Ralph Paone; Suthipong Soontrapa; Zhaoyang Fan; Shu Wang
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

3.  Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation.

Authors:  Beatrice Oehler; Katrin Kistner; Corinna Martin; Jürgen Schiller; Rafaela Mayer; Milad Mohammadi; Reine-Solange Sauer; Milos R Filipovic; Francisco R Nieto; Jan Kloka; Diana Pflücke; Kerstin Hill; Michael Schaefer; Marzia Malcangio; Peter W Reeh; Alexander Brack; Robert Blum; Heike L Rittner
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

4.  Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.

Authors:  Xuchu Que; Ming-Yow Hung; Calvin Yeang; Ayelet Gonen; Thomas A Prohaska; Xiaoli Sun; Cody Diehl; Antti Määttä; Dalia E Gaddis; Karen Bowden; Jennifer Pattison; Jeffrey G MacDonald; Seppo Ylä-Herttuala; Pamela L Mellon; Catherine C Hedrick; Klaus Ley; Yury I Miller; Christopher K Glass; Kirk L Peterson; Christoph J Binder; Sotirios Tsimikas; Joseph L Witztum
Journal:  Nature       Date:  2018-06-06       Impact factor: 49.962

5.  Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages.

Authors:  Soo-Ho Choi; Huiyong Yin; Amir Ravandi; Aaron Armando; Darren Dumlao; Jungsu Kim; Felicidad Almazan; Angela M Taylor; Coleen A McNamara; Sotirios Tsimikas; Edward A Dennis; Joseph L Witztum; Yury I Miller
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.